< Back to previous page
Researcher
Karel Allegaert
- Disciplines:Paediatrics, Pharmacology not elsewhere classified, Neonatology
Affiliations
- Clinical Pharmacology and Pharmacotherapy (Division)
Member
From1 Oct 2019 → 30 Sep 2022 - Woman and Child (Division)
Member
From1 Apr 2013 → 30 Sep 2022
Infrastructure
1 - 1 of 1
Projects
1 - 10 of 22
- Handling of social determinants in pharmacokinetics-pharmacodynamics analyses to enhance equity and inclusion in drug dosing in neonates, children, and adolescentsFrom4 Jan 2024 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Using ‘real-world’ data to gain knowledge on medication safety during pregnancy: towards a ‘fit-for-purpose’ registration system on maternal medication use and mother-infant outcomes (BELpREG).From1 Oct 2023 → TodayFunding: BOF - postdoctoral mandates
- Antibacterial dose optimisation based on augmented renal clearance in adult critically ill patients and selected pediatric patientsFrom1 Oct 2021 → 30 Sep 2022Funding: BOF - postdoctoral mandates
- Exploration of the pharmacokinetics of clindamycin and its metabolites in special patients: from bioanalysis to clinical relevanceFrom1 Oct 2021 → 30 Sep 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Drug exposure through lactation: providing neonatal physiology to improve pharmacokinetic predictionsFrom21 Sep 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- External and Internal Drivers of Unhealthy AgeingFrom8 Sep 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Beyond optimising drug exposure: Pharmacodynamic models to bridge the gap between exposure and response to antimicrobial treatmentsFrom15 Jul 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- The development and validation of a prototype of a Belgian data registration system on medication use during pregnancy and lactation (BELpREG-project)From1 Jan 2021 → 31 Dec 2022Funding: IOF - technology validation in lab
- In vitro and in silico investigation of pharmacokinetics in neonates undergoing therapeutic hypothermiaFrom26 Nov 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- I-PREDICT: Innovative Physiology-based pharmacokinetic model to pREdict Drug exposure In neonates undergoing Cooling TherapyFrom1 Jan 2020 → 31 Dec 2023Funding: FWO research project (including WEAVE projects)
Publications
21 - 30 of 743
- Challenges of Antibiotic Formulations and Administration in the Treatment of Bloodstream Infections in Children Under Five Admitted to Kisantu Hospital, Democratic Republic of Congo(2023)
Authors: Bieke Tack, Jaan Toelen, Karel Allegaert, Jan Jacobs
Pages: 1245 - 1259 - Management of preterm labor: Clinical practice guideline and recommendation by the WAPM-World Association of Perinatal Medicine and the PMF-Perinatal Medicine Foundation(2023)
Authors: Karel Allegaert
Pages: 196 - 205 - Blood pressure and renal function responses in workers exposed to lead for up to six years(2023)
Authors: Peter Verhamme, Karel Allegaert, Tim Nawrot
Pages: 1086 - 1095 - Oral and Intravenous Amoxicillin Dosing Recommendations in Neonates: A Pooled Population Pharmacokinetic Study(2023)
Authors: Karel Allegaert
Pages: 1595 - 1603 - Challenges Related to Acquisition of Physiological Data for Physiologically Based Pharmacokinetic (PBPK) Models in Postpartum, Lactating Women and Breastfed Infants—A Contribution from the ConcePTION Project(2023)
Authors: Martje Van Neste, Annick Bogaerts, Nina Nauwelaerts, Anne Smits, Pieter Annaert, Karel Allegaert
- A Callout for International Collaboration. Reply to Giger, E.V.; Tilen, R. Comment on "Shaniv et al. Neonatal Drug Formularies-A Global Scope. Children 2023, 10, 848"(2023)
Authors: Anne Smits, Karel Allegaert
- Doxapram versus placebo in preterm newborns: a study protocol for an international double blinded multicentre randomized controlled trial (DOXA-trial)(2023)
Authors: Anne Smits, Karel Allegaert
- Assessment of in vitro antimicrobial activity of clindamycin metabolites against Staphylococcus species(2023)
Authors: Greet Van De Sijpe, Karel Allegaert, Jef Rozenski, Pieter Annaert, Stefanie Desmet
Pages: 1345 - 1347 - Assessment of in vitro antimicrobial activity of clindamycin metabolites against Staphylococcus species(2023)
Authors: Greet Van De Sijpe, Laura Armengol Álvarez, Agustos Cetin Ozbey, Karel Allegaert, Jef Rozenski, Pieter Annaert, Stefanie Desmet, Isabel Spriet
Pages: 1345 - 1347 - What Mothers Know about Newborn Bloodspot Screening and the Sources They Use to Acquire This Knowledge: A Pilot Study in Flanders(2023)
Authors: Maissa Rayyan, Karel Allegaert